Stille holds 2026 annual general meeting
Resolutions include adopting financial statements, no dividend, board re-elections, and issue authorization. Meeting occurred on May 7, 2026, in Stockholm.
See the latest news and media coverage for Stille. We track all announcements, press releases, and industry mentions in real time, all in one place.
Manufacturer of surgical instruments and C-arm tables
stille.seLast updated
In short: Stille reported a 38.5% increase in Q1 2026 sales, appointed a new CEO and executive team, and completed the acquisition of Surgical Holdings.
Resolutions include adopting financial statements, no dividend, board re-elections, and issue authorization. Meeting occurred on May 7, 2026, in Stockholm.
Net sales reach MSEK 179.1, up 38.5%. Gross margin is 49.1%. EBITDA before non-recurring items is MSEK 38.5.
The report publishes April 24, 2026, at 8:00 CET. CEO and CFO present via webcast at 14:00 CET, followed by Q&A. Registration required.
The meeting occurs on May 7, 2026, at 14:00 CEST in Stockholm. It includes adoption of financial statements, board elections, and issue authorization. No dividend proposed.
The 2026 annual general meeting in Stille AB was held on May 7, 2026, in Stockholm. The main resolutions passed at the annual general meeting...
Net sales amounted to MSEK 174.9 (161.2), an increase of 8.5 percent (negative organic growth of 6.1 percent). The quarter was negatively impacted by the...
The medical technology company Stille reported an operating profit of 16.6 million kronor (25.7) for the second quarter of 2025. Net sales were 124.7 million kronor (142.6). Cash flow from continuing...
The First North-listed medical technology company Stille, whose CEO Torbjörn Sköld in December announced that he planned to leave his role in June, has appointed a successor: Ulrik Berthelsen...
Track Stille and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Stille and other trending companies.